Nu-Med Plus (NUMD) Cash & Current Investments (2011 - 2025)
Nu-Med Plus recorded quarterly Cash & Current Investments of $661.0 in Q4 2025, down 66.07% quarter-over-quarter from $1948.0 in Q3 2025, and down 72.14% year-over-year from $2373.0 in Q4 2024.
Nu-Med Plus' Cash & Current Investments history runs 15 years deep, the most recent figure standing at $661.0 for Q4 2025.
- In Q4 2025, Cash & Current Investments fell 72.14% year-over-year to $661.0; the TTM figure through Dec 2025 stood at $661.0 (down 72.14% YoY), while the FY2025 annual figure was $661.0, down 72.14% from the prior year.
- Cash & Current Investments came in at $661.0 for Q4 2025 at Nu-Med Plus, down from $1948.0 in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $139265.0 in Q1 2021 to a low of $628.0 in Q3 2022.
- A 5-year average of $23974.1 and a median of $6356.0 in 2024 frame the typical range for Cash & Current Investments.
- Across the five-year window, Cash & Current Investments plunged 98.18% in 2022 and surged 1990.22% in 2023, its largest moves.
- Nu-Med Plus' Cash & Current Investments stood at $11675.0 in 2021, then jumped by 526.94% to $73195.0 in 2022, then sank by 90.7% to $6806.0 in 2023, then slumped by 65.13% to $2373.0 in 2024, then sank by 72.14% to $661.0 in 2025.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $661.0, $1948.0, and $863.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 8.38 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.12 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1.12 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 439.60 Mn |
| 10 | Nu-Med Plus | - | - | - | 661.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 661.00 |
| Sep 30, 2025 | 1,948.00 |
| Jun 30, 2025 | 863.00 |
| Mar 31, 2025 | 2,373.00 |
| Dec 31, 2024 | 2,373.00 |
| Sep 30, 2024 | 4,041.00 |
| Jun 30, 2024 | 4,041.00 |
| Mar 31, 2024 | 6,356.00 |
| Dec 31, 2023 | 6,806.00 |
| Sep 30, 2023 | 11,088.00 |
| Jun 30, 2023 | 29,957.00 |
| Mar 31, 2023 | 53,029.00 |
| Dec 31, 2022 | 73,195.00 |
| Sep 30, 2022 | 628.00 |
| Mar 31, 2022 | 2,537.00 |
| Dec 31, 2021 | 11,675.00 |
| Sep 30, 2021 | 31,840.00 |
| Jun 30, 2021 | 72,831.00 |
| Mar 31, 2021 | 139,265.00 |
| Dec 31, 2020 | 188,506.00 |
| Sep 30, 2020 | 31,498.00 |
| Jun 30, 2020 | 6,106.00 |
| Mar 31, 2020 | 18,328.00 |
| Dec 31, 2019 | 7,079.00 |
| Sep 30, 2019 | 41,838.00 |
| Jun 30, 2019 | 15,686.00 |
| Mar 31, 2019 | 23,276.00 |
| Dec 31, 2018 | 167,513.00 |
| Sep 30, 2018 | 168,262.00 |
| Jun 30, 2018 | 288,398.00 |
| Mar 31, 2018 | 275,420.00 |
| Dec 31, 2017 | 351,043.00 |
| Sep 30, 2017 | 409,313.00 |
| Jun 30, 2017 | 263,539.00 |
| Mar 31, 2017 | 315,547.00 |
| Dec 31, 2016 | 12,450.00 |
| Sep 30, 2016 | 1,383.00 |
| Jun 30, 2016 | 37,831.00 |
| Mar 31, 2016 | 87,640.00 |
| Dec 31, 2015 | 30,903.00 |
| Sep 30, 2015 | 211.00 |
| Jun 30, 2015 | 10,708.00 |
| Mar 31, 2015 | 12,981.00 |
| Dec 31, 2014 | 56,271.00 |
| Sep 30, 2014 | 56,271.00 |
| Jun 30, 2014 | 39,371.00 |
| Mar 31, 2014 | 7,750.00 |
| Dec 31, 2013 | 13,229.00 |
| Sep 30, 2013 | 8,339.00 |
| Jun 30, 2013 | 8,251.00 |
| Mar 31, 2013 | 3,716.00 |
| Dec 31, 2012 | 731.00 |
| Sep 30, 2012 | 185.00 |
| Jun 30, 2012 | 16,947.00 |
| Mar 31, 2012 | 58,928.00 |
| Dec 31, 2011 | 870.00 |